Latest News

“[O]ur findings show that large-scale lung cancer screening is both feasible and effective, and provide a framework for successful delivery of a population-based national program,” according to the study authors.
Low-Dose CT Screening for Lung Cancer Shows Large-Scale Efficacy

April 29th 2025

Study data show a small number of individuals with a lung cancer diagnosis within 12 months of a negative baseline screening result.

Chemoimmunotherapy Enhanced Survival vs Chemo Alone in ES-SCLC
Chemoimmunotherapy Enhanced Survival vs Chemo Alone in ES-SCLC

April 27th 2025

Findings from a multicenter cohort study support screening adherence as a key lung cancer screening quality metric.
Lung Cancer Screening Adherence Decreases Across Subsequent Testing

April 24th 2025

A systematic review shows that well-designed randomized clinical trials are necessary to optimize treatment strategies with tislelizumab in lung cancer.
Tislelizumab Significantly Boosts Survival in Lung Cancer Trials

April 23rd 2025

“These results and the lack of systemic toxicity observed with [TTFields] provide patients with a promising new treatment option,” according to Joachim Aerts, MD, an investigator of the phase 3 LUNAR trial (NCT02973789).
TTFields Therapy Earns EU Approval in Metastatic Non–Small Cell Lung Cancer

April 23rd 2025

Video Series
Video Interviews
Podcasts
Georgios Evangelou, MD, MSc, speaks to the potential utility of neoadjuvant capecitabine/temozolomide in well-differentiated atypical carcinoids.
Rian M. Hasson Charles, MD, MPH, FACS, discusses advances in equitable lung cancer screening and her experiences as a woman in thoracic oncology.

More News